Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Instadose Pharma Corp (OP: INSD ) N/A UNCHANGED Last Price Updated: 9:36 AM EST, Feb 27, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.0011 Today's Range N/A - N/A 52wk Range N/A - N/A Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Summary Notice of Pendency of Class Action November 30, 2023 From Bragar Eagel & Squire, P.C. Via Business Wire OTC:INSD Long Term Shareholder Notice: Investigation of Potential Wrongdoing at Instadose Pharma Corp. April 22, 2022 San Diego, CA -- (SBWIRE) -- 04/22/2022 -- An investigation was announced for long-term investors in shares of Instadose Pharma Corp. (OTC:INSD) concerning potential breaches of fiduciary duties by... Via SBWire Performance More News Read More Final Deadline Alert: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm February 28, 2022 Via NewMediaWire Topics Lawsuit Exposures Financial Legal INSD MONDAY DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Instadose Pharma Corp. f/k/a Mikrocoze, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Monday Deadline in Securities Class Action INSD, MZKR February 26, 2022 Via NewMediaWire INSTADOSE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Instadose Pharma Corp. and Encourages Investors to Contact the Firm February 25, 2022 From Bragar Eagel & Squire, P.C. Via Business Wire The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (INSD) February 25, 2022 From The Law Offices of Frank R. Cruz Via Business Wire Monday Deadline Reminder: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm February 25, 2022 Via NewMediaWire Topics Lawsuit Exposures Financial Legal Deadline Monday Alert: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm February 23, 2022 Via NewMediaWire Topics Lawsuit Exposures Financial Legal OTC:INSD Investor Notice: Deadline on February 28, 2022 in Lawsuit Against Instadose Pharma Corp. February 23, 2022 Via SBWire Monday Deadline Reminder: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm February 22, 2022 Via NewMediaWire Topics Lawsuit Exposures Financial Legal 7-Day Deadline Reminder: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm February 21, 2022 Via NewMediaWire Topics Lawsuit Exposures Financial Legal Shareholder Action Reminder: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm February 18, 2022 Via NewMediaWire Topics Lawsuit Exposures Financial Legal Investor Action Notice: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm February 17, 2022 Via NewMediaWire Topics Lawsuit Exposures Financial Legal Investor Action Notice: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm February 01, 2022 Via NewMediaWire Topics Lawsuit Exposures Financial Legal Investor Action Alert: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm January 31, 2022 Via NewMediaWire Topics Lawsuit Exposures Financial Legal Shareholder Action Reminder: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm January 28, 2022 Via NewMediaWire Topics Lawsuit Exposures Financial Legal Investor Action Alert: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm January 26, 2022 Via NewMediaWire Topics Lawsuit Exposures Financial Legal Shareholder Action Reminder: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm January 25, 2022 Via NewMediaWire Topics Lawsuit Exposures Financial Legal Investor Action Notice: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm January 24, 2022 Via NewMediaWire Topics Lawsuit Exposures Financial Legal OTC: INSD Investor Notice: Lawsuit Alleges Securities Laws Violations by Instadose Pharma Corp January 24, 2022 Via SBWire Investor Action Alert: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm January 21, 2022 Via NewMediaWire Topics Lawsuit Exposures Financial Legal Shareholder Action Reminder: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm January 20, 2022 Via NewMediaWire Topics Lawsuit Exposures Financial Legal Shareholder Action Reminder: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm January 19, 2022 Via NewMediaWire Topics Lawsuit Exposures Financial Legal Cannabis Movers & Shakers: Columbia Care, Lowell Farms, Leafly, Instadose, Michael J. Fox Foundation January 19, 2022 Via Benzinga Investor Action Alert: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm January 18, 2022 Via NewMediaWire Topics Lawsuit Exposures Financial Legal Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.